先进制造业知识服务平台
国家科技图书文献中心机械分馆  工信部产业技术基础公共服务平台  国家中小企业公共服务示范平台

OA期刊


ISSN1942-0862
刊名Mabs
出版商Taylor & Francis Inc.
urlhttps://www.tandfonline.com/loi/kmab20
机构Taylor & Francis Ltd.



全部

2010 2011 2012 2013 2014 2015
2016 2017 2018 2019 2020 2021
2022 2023 2024 2025

2018, vol.10, no.1 2018, vol.10, no.2 2018, vol.10, no.3 2018, vol.10, no.4 2018, vol.10, no.5 2018, vol.10, no.6
2018, vol.10, no.7 2018, vol.10, no.8

题名作者出版年年卷期
Enhancing antibody patent protection using epitope mapping informationXiaoxiang Deng;Ulrich Storz;Benjamin J. Doranz;20182018, vol.10, no.2
Establishing in vitro in vivo correlations to screen monoclonal antibodies for physicochemical properties related to favorable human pharmacokineticsLindsay B. Avery;Jason Wade;Mengmeng Wang;Amy Tam;Amy King;Nicole Piche-Nicholas;Mania S. Kavosi;Steve Penn;David Cirelli;Jeffrey C. Kurz;Minlei Zhang;Orla Cunningham;Rhys Jones;Brian J. Fennell;Barry McDonnell;Paul Sakorafas;James Apgar;William J. Finlay;Laura Lin;Laird Bloom;Denise M. O'Hara;20182018, vol.10, no.2
Challenges and new frontiers in analytical characterization of antibody-drug conjugatesAnil Wagh;Hangtian Song;Ming Zeng;Li Tao;Tapan K. Das;20182018, vol.10, no.2
Antibody-drug conjugates: Design and development for therapy and imaging in and beyond cancer, LabEx MAbImprove industrial workshop, July 27–28, 2017, Tours, FranceCamille Martin;Claire Kizlik-Masson;André Pèlegrin;Hervé Watier;Marie-Claude Viaud-Massuard;Nicolas Joubert;20182018, vol.10, no.2
Antibodies to watch in 2018Hélène Kaplon;Janice M. Reichert;20182018, vol.10, no.2
Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responsesBoning Liu;Huaizu Guo;Jin Xu;Ting Qin;Qingcheng Guo;Nana Gu;Dapeng Zhang;Weizhu Qian;Jianxin Dai;Sheng Hou;Hao Wang;Yajun Guo;20182018, vol.10, no.2
Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous systemGeorge Thom;Jon Hatcher;Arron Hearn;Judy Paterson;Natalia Rodrigo;Arthur Beljean;Ian Gurrell;Carl Webster;20182018, vol.10, no.2
Development of a pre-glycoengineered CHO-K1 host cell line for the expression of antibodies with enhanced Fc mediated effector functionOliver Popp;Samuel Moser;Jörg Zielonka;Petra Rüger;Silke Hansen;Oliver Plöttner;20182018, vol.10, no.2
Note of appreciation to reviewersJanice M. Reichert;20182018, vol.10, no.2
Engineered aglycosylated full-length IgG Fc variants exhibiting improved FcγRIIIa binding and tumor cell clearanceMigyeong Jo;Hyeong Sun Kwon;Kwang-Hoon Lee;Ji Chul Lee;Sang Taek Jung;20182018, vol.10, no.2
12